Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Import Task Force Seeks Health Canada Input As It Prepares Final Report

Executive Summary

The HHS drug importation task force will seek to have factual discrepancies in testimony clarified it prepares to write its final report
Advertisement

Related Content

Canada-Only Import Plan “Feasible,” HHS Says: Savings Would Be “Modest”
Canada-Only Import Plan “Feasible,” HHS Says: Savings Would Be “Modest”
FDA, CMS Changes Likely After Thompson Departs; Opening For Rx Imports?
FDA, CMS Changes Likely After Thompson Departs; Opening For Rx Imports?
Reimportation Can Be Stopped, Sen. Santorum Says
Reimportation Can Be Stopped, Sen. Santorum Says
Rx Imports: President Bush Says Decision Could Come In December
Rx Imports: President Bush Says Decision Could Come In December
Wholesalers Crucial To Safe Rx Importation Scheme, HDMA Tells Task Force
Wholesalers Crucial To Safe Rx Importation Scheme, HDMA Tells Task Force
Advertisement
UsernamePublicRestriction

Register

PS044016

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel